Skip to content

Savara SVRA Common Stock

Common Stock at other companies

XER
Xeris Biopharma Holdings, Inc.XERS
$18K+12.5%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$738K+17.5%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$6K+20.0%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$3K+50.0%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$1K0.0%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$27K0.0%

Other financials

Income statement

See full
Revenue-
Operating income-$39.0M-37.1%
Net income-$37.3M-40.0%
EPS (diluted)-$0.15-25.0%

Balance sheet

See full
Cash & equivalents$38.8M+98.4%
Total debt$30.1M+1.8%
Total equity$176.0M+19.1%
Total assets$221.6M+17.1%

Cash flow

See full
Operating cash flow-$33.0M-21.5%
CapEx$54.0K+1,700%
Free cash flow-$33.1M-21.7%

Valuation

See full
Market cap$1.24B+247%
Enterprise value$1.23B+235%
P/S4,808.2×

Profitability

See full
Operating margin-19,183.3%
Net margin-19,305.1%
FCF margin-15,518.7%

Returns & leverage

See full
Return on equity-80%+4.7pp
Debt / equity0.2×0.0×
Current ratio13.5×-1.4×

Where this comes from

Reported directly by Savara in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Savara’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Savara's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Savara's common stock?
Savara (SVRA) reported common stock of $204K in Q1 2026.
How has Savara's common stock changed year-over-year?
Savara's common stock increased by 17.9% year-over-year, from $173K to $204K.
What is the long-term trend for Savara's common stock?
Over 5 years (2020 to 2025), Savara's common stock has grown at a 30.0% compound annual growth rate (CAGR), from $55K to $204K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).